As com­pa­nies dump mon­ey in­to man­u­fac­tur­ing, where will they find the trained work­ers to staff the lines?

With more mon­ey than ever flow­ing through bio­phar­ma, the mas­sive de­mand for scal­able man­u­fac­tur­ing has cre­at­ed a big crunch on find­ing and train­ing a sta­ble work­force. With the work nev­er stop­ping, some com­pa­nies are des­per­ate­ly try­ing to fig­ure out how to at­tract more qual­i­fied em­ploy­ees.

Craig Mein­hardt, Pfiz­er’s di­rec­tor of man­u­fac­tur­ing op­er­a­tions, and Jeff Savard, Bris­tol My­ers Squibb’s di­rec­tor of man­u­fac­tur­ing, were among a dozen peo­ple in a break­out room in Mass­BioEd 2021 Life Sci­ences Work­force Con­fer­ence on Wednes­day. To a group filled with bio­phar­ma ex­ec­u­tives, aca­d­e­mics and ca­reer coun­selors, they fo­cused on three key is­sues in hir­ing for man­u­fac­tur­ing: How do you get peo­ple to fill these roles, where do you find them and how do you train them?

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.